PharmaLundensis (PHAL)

PharmaLundensis is a research company. Main focus is on the treatment of severe pulmonary diseases. The three diseases the company is specialised in include chronic obstructive pulmonary disease (COPD), chronic bronchitis, and influenza-induced lung failure. In addition, development is made on system that eliminates the release of pharmaceutical pollution. PharmaLundensis is based in Lund.

Quotes for PharmaLundensis AB

Right Now

+/-: 0.042
%: 8,14%
Latest: 0.558
High: 0.558
Low: 0.401
Volume: 32 768
Turnover (SEK): 17 217
Market Value (MSEK): 29,7
Time (Latest trade): 2025-05-12 12:18

Board

CEO

Staffan Skogvall

Chairperson of the Board

Björn Sivik (tf)

Board

Bo Wennergren
Björn Sivik
Staffan Skogvall
Stefan Ahlfors

Articles of association

News

2025-05-05 16:48:24 KV1 konverterades till 147 598 aktier
2025-04-28 19:30:38 Q1 rapport publiceras på torsdag den 15:e maj
2025-04-09 22:08:57 Praktisk information kring omvandling av KV1 till aktier
2025-04-08 17:00:06 Framgångsrik testning av förevaporeringsenhet
2025-04-04 13:04:01 Kompletterande information avseende konvertering av KV1 till aktier

News agencies

2025-05-05 17:01:40 Finwire: Pharmalundensis KV1 konverteras till 147 598 aktier (uppdatering)
2025-05-05 16:59:02 Finwire: Pharmalundensis KV1 konverteras till 147 498 aktier
2025-04-08 17:32:47 Finwire: Pharmalundensis rapporterar om framgångsrik testning av förevaporeringsenhet
2025-04-01 15:23:41 Finwire: Pharmalundensis tillförs knappt 0,3 miljoner kronor från utnyttjande av TO 7
2025-02-28 15:26:21 Finwire: Pharmalundensis företrädesemission tecknades till 19 procent

Analysis

2018-10-29 SvD Börsplus: PharmaLundensis: Aktien kan stiga 4000% (enligt vd)

Largest Owners

Name	Capital %	Votes %	Date
Staffan Skogvall	51,56	51,56	2025-03-27
Vict Th Engwalls Stiftelse	2,61	2,61	2025-03-27
Arne Skogvall	2,09	2,09	2025-03-27
Arne Arvidsson	1,88	1,88	2025-03-27
Avanza Pension	1,14	1,14	2025-03-27
Nordnet Pensionsförsäkring	0,70	0,70	2025-03-27
Tommy Johansson	0,66	0,66	2025-03-27
Staffan Engelbert Bodén	0,57	0,57	2025-03-27
Merrick Lee Tabor	0,42	0,42	2025-03-27
Monica Billgert	0,42	0,42	2025-03-27

** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

*Source: Holdings by Modular Finance AB. Compiled and processed data from the Swedish Financial Supervisory Authority

PharmaLundensis AB